155 related articles for article (PubMed ID: 34383599)
1. Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors.
Cullinan N; Schiller I; Di Giuseppe G; Mamun M; Reichman L; Cacciotti C; Wheaton L; Caswell K; Di Monte B; Gibson P; Johnston DL; Fleming A; Pole JD; Malkin D; Foulkes WD; Dendukuri N; Goudie C; Nathan PC
J Clin Oncol; 2021 Oct; 39(29):3207-3216. PubMed ID: 34383599
[TBL] [Abstract][Full Text] [Related]
2. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.
Goudie C; Witkowski L; Cullinan N; Reichman L; Schiller I; Tachdjian M; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Clark ME; Clinton C; Coltin H; Felton K; Fernandez CV; Fleming AJ; Fuentes-Bolanos N; Gibson P; Grant R; Hammad R; Harrison LW; Irwin MS; Johnston DL; Kane S; Lafay-Cousin L; Lara-Corrales I; Larouche V; Mathews N; Meyn MS; Michaeli O; Perrier R; Pike M; Punnett A; Ramaswamy V; Say J; Somers G; Tabori U; Thibodeau ML; Toupin AK; Tucker KM; van Engelen K; Vairy S; Waespe N; Warby M; Wasserman JD; Whitlock JA; Sinnett D; Jabado N; Nathan PC; Shlien A; Kamihara J; Deyell RJ; Ziegler DS; Nichols KE; Dendukuri N; Malkin D; Villani A; Foulkes WD
JAMA Oncol; 2021 Dec; 7(12):1806-1814. PubMed ID: 34617981
[TBL] [Abstract][Full Text] [Related]
3. Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes.
Hebert R; Cullinan N; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Coltin H; Deyell RJ; Felton K; Fernandez CV; Fleming AJ; Gibson P; Hammad R; Jabado N; Johnston DL; Lafay-Cousin L; Larouche V; Leblanc-Desrochers C; Michaeli O; Perrier R; Pike M; Say J; Schiller I; Toupin AK; Vairy S; van Engelen K; Waespe N; Villani A; Foulkes WD; Malkin D; Reichman L; Goudie C
J Med Genet; 2023 Nov; 60(12):1218-1223. PubMed ID: 37460202
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
[TBL] [Abstract][Full Text] [Related]
5. Obesity and Risk for Second Malignant Neoplasms in Childhood Cancer Survivors: A Case-Control Study Utilizing the California Cancer Registry.
Moke DJ; Hamilton AS; Chehab L; Deapen D; Freyer DR
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1612-1620. PubMed ID: 31337641
[TBL] [Abstract][Full Text] [Related]
6. Incidence, Risk Factors, and Mortality Associated With Second Malignant Neoplasms Among Survivors of Adolescent and Young Adult Cancer.
Chao C; Bhatia S; Xu L; Cannavale KL; Wong FL; Huang PS; Cooper R; Armenian SH
JAMA Netw Open; 2019 Jun; 2(6):e195536. PubMed ID: 31173129
[TBL] [Abstract][Full Text] [Related]
7. Polygenic Risk and Chemotherapy-Related Subsequent Malignancies in Childhood Cancer Survivors: A Childhood Cancer Survivor Study and St Jude Lifetime Cohort Study Report.
Im C; Sharafeldin N; Yuan Y; Wang Z; Sapkota Y; Lu Z; Spector LG; Howell RM; Arnold MA; Hudson MM; Ness KK; Robison LL; Bhatia S; Armstrong GT; Neglia JP; Yasui Y; Turcotte LM
J Clin Oncol; 2023 Sep; 41(27):4381-4393. PubMed ID: 37459583
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and survival patterns of subsequent sarcoma, breast cancer, and melanoma after childhood cancer in the DCOG-LATER cohort.
Teepen JC; Kremer LC; van der Heiden-van der Loo M; Tissing WJ; van der Pal HJ; van den Heuvel-Eibrink MM; Loonen JJ; Louwerens M; Versluys B; van Dulmen-den Broeder E; Visser O; Maduro JH; van Leeuwen FE; Ronckers CM;
Cancer Causes Control; 2019 Sep; 30(9):909-922. PubMed ID: 31300947
[TBL] [Abstract][Full Text] [Related]
9. Telomere content and risk of second malignant neoplasm in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
Gramatges MM; Liu Q; Yasui Y; Okcu MF; Neglia JP; Strong LC; Armstrong GT; Robison LL; Bhatia S
Clin Cancer Res; 2014 Feb; 20(4):904-11. PubMed ID: 24277454
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Psychosocial Well-Being and Quality of Life Among Childhood Cancer Survivors Who Developed a Subsequent Malignant Neoplasm.
Lu D; Kenney LB; Vrooman LM; Recklitis CJ
J Adolesc Young Adult Oncol; 2021 Apr; 10(2):240-245. PubMed ID: 32799610
[TBL] [Abstract][Full Text] [Related]
11. Subsequent neoplasms in childhood cancer survivors.
Zichová A; Eckschlager T; Ganevová M; Malinová B; Lukš A; Kruseová J
Cancer Epidemiol; 2020 Oct; 68():101779. PubMed ID: 32682319
[TBL] [Abstract][Full Text] [Related]
12. Treatment-adjusted predisposition to second malignant neoplasms after a solid cancer in childhood: a case-control study.
Guérin S; Hawkins M; Shamsaldin A; Guibout C; Diallo I; Oberlin O; Brugières L; de Vathaire F
J Clin Oncol; 2007 Jul; 25(19):2833-9. PubMed ID: 17602088
[TBL] [Abstract][Full Text] [Related]
13. Second malignant neoplasms among children, adolescents and young adults with Wilms tumor.
Lee JS; Padilla B; DuBois SG; Oates A; Boscardin J; Goldsby RE
Pediatr Blood Cancer; 2015 Jul; 62(7):1259-64. PubMed ID: 25809878
[TBL] [Abstract][Full Text] [Related]
14. Increased Cardiac Risk After a Second Malignant Neoplasm Among Childhood Cancer Survivors: A FCCSS Study.
Charrier T; Haddy N; Schwartz B; Journy N; Fresneau B; Demoor-Goldschmidt C; Diallo I; Surun A; Aerts I; Doz F; Souchard V; Vu-Bezin G; Laprie A; Lemler S; Letort V; Rubino C; Chounta S; de Vathaire F; Latouche A; Allodji RS
JACC CardioOncol; 2023 Dec; 5(6):792-803. PubMed ID: 38205003
[TBL] [Abstract][Full Text] [Related]
15. Local radiation dose and solid second malignant neoplasms after childhood cancer in Germany: a nested case-control study.
Hennewig U; Kaatsch P; Blettner M; Spix C
Radiat Environ Biophys; 2014 Aug; 53(3):485-93. PubMed ID: 24859016
[TBL] [Abstract][Full Text] [Related]
16. Short NK- and Naïve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study.
Man TK; Aubert G; Richard MA; LeJeune W; Hariri E; Goltsova T; Gaikwad A; Chen Y; Whitton J; Leisenring WM; Arnold MA; Neglia JP; Yasui Y; Robison LL; Armstrong GT; Bhatia S; Gramatges MM
Cancer Epidemiol Biomarkers Prev; 2022 Feb; 31(2):453-460. PubMed ID: 34782395
[TBL] [Abstract][Full Text] [Related]
17. Subsequent Malignant Neoplasms in a Population-Based Cohort of Pediatric Cancer Patients: A Focus on the First 5 Years.
Pole JD; Gu LY; Kirsh V; Greenberg ML; Nathan PC
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1585-92. PubMed ID: 26189768
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors and Trends for HPV-Associated Subsequent Malignant Neoplasms among Adolescent and Young Adult Cancer Survivors.
Ou JY; Bennion N; Parker K; Fair D; Hanson HA; Kepka D; Warner EL; Ramsay JM; Kaddas HK; Kirchhoff AC
Cancer Epidemiol Biomarkers Prev; 2023 May; 32(5):625-633. PubMed ID: 37071501
[TBL] [Abstract][Full Text] [Related]
19. Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control study.
Guérin S; Guibout C; Shamsaldin A; Dondon MG; Diallo I; Hawkins M; Oberlin O; Hartmann O; Michon J; Le Deley MC; de Vathaire F
Int J Cancer; 2007 Jan; 120(1):96-102. PubMed ID: 17013899
[TBL] [Abstract][Full Text] [Related]
20. Risk factors associated with secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study.
Henderson TO; Rajaraman P; Stovall M; Constine LS; Olive A; Smith SA; Mertens A; Meadows A; Neglia JP; Hammond S; Whitton J; Inskip PD; Robison LL; Diller L
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):224-30. PubMed ID: 22795729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
